Security key
816212302
Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)
CUSIP: 816212302
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 26,658,100
- Total 13F shares
- 6,665,799
- Share change
- -204,176
- Total reported value
- $119,478,509
- Price per share
- $17.91
- Number of holders
- 64
- Value change
- -$2,692,613
- Number of buys
- 37
- Number of sells
- 18
Report period
Q4 2024
Institutions
64
Top holders
10
RNAC full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Cartesian Therapeutics, Inc. SEC filings
Cartesian Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 816212302
Recent filing periods:
Top shareholders of RNAC - Cartesian Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
2,851,830
|
$45,971,500 | — | 30 Sep 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
2.4%
|
629,423
|
$10,146,299 | — | 30 Sep 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
2.1%
|
572,236
|
$9,224,444 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.6%
|
423,466
|
$6,826,277 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
375,767
|
$5,759,450 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
309,018
|
$4,981,371 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.91%
|
243,089
|
$3,918,594 | — | 30 Sep 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.75%
|
200,000
|
$3,224,000 | — | 30 Sep 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.65%
|
173,566
|
$2,801,022 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.59%
|
157,495
|
$2,538,819 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
135,700
|
$2,187,625 | — | 30 Sep 2024 | |
| YALE UNIVERSITY |
13F
|
Company |
0.38%
|
100,000
|
$1,612,000 | — | 30 Sep 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.37%
|
98,565
|
$1,588,868 | — | 30 Sep 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.28%
|
75,431
|
$1,215,948 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
63,115
|
$1,017,414 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.2%
|
52,193
|
$841,352 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.19%
|
50,000
|
$797,940 | — | 30 Sep 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.19%
|
49,497
|
$797,892 | — | 30 Sep 2024 | |
| Freestone Capital Holdings, LLC |
13F
|
Company |
0.1%
|
25,921
|
$417,847 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.09%
|
24,210
|
$390,266 | — | 30 Sep 2024 | |
| DELPHI FINANCIAL GROUP, INC. |
13F
|
Company |
0.08%
|
22,028
|
$355,091 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
22,011
|
$354,818 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
19,048
|
$307,054 | — | 30 Sep 2024 | |
| LAKE STREET ADVISORS GROUP, LLC |
13F
|
Company |
0.06%
|
15,822
|
$255,051 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
15,102
|
$243,444 | — | 30 Sep 2024 | |
| IRONWOOD INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.05%
|
14,631
|
$235,852 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
14,518
|
$234,030 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
12,911
|
$208,125 | — | 30 Sep 2024 | |
| TWIN FOCUS CAPITAL PARTNERS, LLC |
13F
|
Company |
0.05%
|
12,000
|
$193,440 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
11,611
|
$187,169 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
11,336
|
$182,736 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
10,393
|
$167,535 | — | 30 Sep 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
10,193
|
$164,311 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
9,274
|
$149,489 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
7,570
|
$122,028 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
5,339
|
$86,065 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
5,217
|
$84,098 | — | 30 Sep 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
5,102
|
$82,244 | — | 30 Sep 2024 | |
| Johnson Financial Group, Inc. |
13F
|
Company |
0.02%
|
4,618
|
$74,443 | — | 30 Sep 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.01%
|
3,997
|
$64,432 | — | 30 Sep 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.01%
|
3,864
|
$62,288 | — | 30 Sep 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.01%
|
3,715
|
$669 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
3,638
|
$58,645 | — | 30 Sep 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
2,938
|
$47,000 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
2,279
|
$36,737 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
1,761
|
$28,000 | — | 30 Sep 2024 | |
| Laurie J. Trustee Hall |
13F
|
Individual |
0.01%
|
1,759
|
$28,000 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
1,651
|
$26,614 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
801
|
$12,912 | — | 30 Sep 2024 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
708
|
$11,413 | — | 30 Sep 2024 |
Institutional Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) as of Q4 2024
As of 31 Dec 2024,
Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,665,799 shares.
The largest 10 holders included
FMR LLC, MPM BIOIMPACT LLC, BlackRock, Inc., Siren, L.L.C., VANGUARD GROUP INC, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Erste Asset Management GmbH, and STATE STREET CORP.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
61
Q4 2024 holders
64
Holder diff
3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.